Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of aMMP-8 and IL-1β Levels and Marginal Bone Loss Associated With Peri-Implant Mucositis and Peri-Implantitis in Postmenopausal Women

NCT07785817 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT07785817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07785817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of aMMP-8 and IL-1β Levels and Marginal Bone Loss Associated With Peri-Implant Mucositis and Peri-Implantitis in Postmenopausal Women
Lead sponsor
Medipol University
Phase
Observational
Overall status
Active, not recruiting
Start date
March 19, 2026
Completion date
February 1, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal peri-implant health, postmenopausal peri-implantitis, postmenopausal peri-mucositis